PSX
42
3
EA
44
-2
HES
59
3
EQT
44
2
TGT
50
2
XOM
48
3
LH
55
2
SWN
70
3
PG
51
-2
VRSK
35
-3
AIG
51
-2
TRIP
60
3
HPE
53
2
WU
16
2
FTI
69
-7
ORLY
64
2
CMCSA
52
6
AVY
54
-14
NFLX
55
-3
MAR
50
3
PSX
42
3
EA
44
-2
HES
59
3
EQT
44
2
TGT
50
2
XOM
48
3
LH
55
2
SWN
70
3
PG
51
-2
VRSK
35
-3
AIG
51
-2
TRIP
60
3
HPE
53
2
WU
16
2
FTI
69
-7
ORLY
64
2
CMCSA
52
6
AVY
54
-14
NFLX
55
-3
MAR
50
3
Financhill
Back

Heroux-Devtek 10K Form

Buy
73

HRX.TO
Heroux-Devtek

Last Price:
31.88
Seasonality Move:
0.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRX.TO News And Ratings

See the #1 stock for the next 7 days that we like better than HRX.TO

HRX.TO Financial Statistics

Sales & Book Value

Annual Sales: $629.77M
Cash Flow: $1.08M
Price / Cash Flow: 0
Annual Sales: $13.20
Price / Book: 2.42

Profitability

EPS (TTM): 1.39000
Net Income (TTM): $46.85M
Gross Margin: $111.07M
Return on Equity: 11.33%
Return on Assets: 5.36%

Heroux-Devtek Earnings Forecast

Key Heroux-Devtek Financial Ratios

  • The Gross Profit Margin over the past 28 years for HRX.TO is 17.64%.
  • The Selling, General & Administrative Expenses for HRX.TO have been equal to 8.78% of Gross Profit Margin.
  • The Research & Development expenses have been 0.37% of Revenue.
  • The Interest Expense is 35.27% of Operating Income.
  • The Net Earning history of HRX.TO is 6.08% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 17 years.

Heroux-Devtek Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: TSX
Industry: Aerospace & Defense
Sector: Industrials
Current Symbol: HRX.TO
Website: herouxdevtek.com

Debt

Debt-to-Equity Ratio: 0.48
Current Ratio: 2.14
Quick Ratio: 0.56

Price-to-Earnings

Trailing P/E Ratio: 28.21
Forward P/E Ratio: 18.51

HRX.TO Technical Analysis vs Fundamental Analysis

Buy
73
Heroux-Devtek (HRX.TO) is a Buy

Is Heroux-Devtek a Buy or a Sell?

  • Heroux-Devtek stock is rated a Buy
    The current Heroux-Devtek [HRX.TO] share price is $31.88. The Score for HRX.TO is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.